HSBC TUR.WAR.OP.END. BBZA/ DE000HG94HK4 /
15/11/2024 15:45:00 | Chg.-0.960 | Bid17:19:18 | Demandez à17:19:18 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
7.900EUR | -10.84% | - Bid taille: 10,000 |
- Ask la taille: 10,000 |
BB BIOTECH N | 30.3934 CHF | 31/12/2078 | Call |
GlobeNewswire
28/03
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire
17/06/2021
Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
GlobeNewswire
16/12/2019
Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire
19/10/2018
Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire
02/01/2018
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire
19/10/2017
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire
02/12/2016
Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire
29/07/2016
Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire
15/07/2016
BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire
14/07/2016
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page